Biopharma Co. Sued After Leukemia Treatment Trial Fails
A TG Therapeutics Inc. stockholder filed a proposed class action in New York federal court on Thursday accusing the biopharmaceutical company of making optimistic statements about the clinical trial performance of...To view the full article, register now.
Already a subscriber? Click here to view full article